Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer

Journal of Thoracic Oncology

Volumn 7, Issue 7, 2012, Pages 1115-1123

  Hung, Jung Jyh ^a   Jeng, Wen Juei ^b   Hsu, Wen Hu ^a   Chou, Teh Ying ^a,c   Huang, Biing Shiun ^a   Wu, Yu Chung ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Distant metastasis; Local recurrence; Non small cell lung cancer; Survival

Indexed keywords

AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LOCAL RECURRENCE FREE SURVIVAL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SURVIVAL RATE;

EID: 84862879720     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31824cbad8     Document Type: Article

References (39)

1. Spira A Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;350:379-392. (Pubitemid 38101633)
2. nd edition). Chest 2007;132(3 Suppl):234S-242S. (Pubitemid 47502810)
3. Sobin L, Wittekind Ch, eds. TNM Classification of Malignant Tumors, 6th Ed. New York: Wiley-Liss, 2002. Pp. 99-103.
4. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717. (Pubitemid 27260107)
5. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-129.
6. Harpole DH Jr, Herndon JE 2nd, Young WG Jr, Wolfe WG, Sabiston DC Jr. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995;76:787-796.
7. Jones DR, Daniel TM, Denlinger CE, Rundall BK, Smolkin ME, Wick MR. Stage IB nonsmall cell lung cancers: are they all the same? Ann Thorac Surg 2006;81:1958-62; discussion 1962. (Pubitemid 43775565)
8. Nakagawa T, Okumura N, Ohata K, Igai H, Matsuoka T, Kameyama K. Postrecurrence survival in patients with stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2008;34:499-504.
9. Sugimura H, Nichols FC, Yang P, et al. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg 2007;83:409-417.
10. Hung JJ, Hsu WH, Hsieh CC, et al. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax 2009;64:192-196.
11. Hung JJ, Jeng WJ, Hsu WH, et al. Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. Thorax 2010;65:241-245.
12. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York: Springer, 2010.
13. th ed. Oxford, UK: Wiley-Blackwell, 2009.
14. Rami-Porta R, Ball D, Crowley J, et al.; International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2:593-602. (Pubitemid 47171780)
15. Goldstraw P, Crowley J, Chansky K, et al.; International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-714. (Pubitemid 47357522)
16. Strauss GM, Herndon JE II, Maddaus MA, et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 9633 [abstract 7007]. J Clin Oncol 2006;24:365S.
17. nd, Maddaus MA, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 2008;26: 5043-5051.
18. Butts CA, Ding K, Seymour L, et al. Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. J Clin Oncol 2010;28:29-34.
19. Hung JJ, Wang CY, Huang MH, Huang BS, Hsu WH, Wu YC. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival. J Thorac Cardiovasc Surg 2007;134:638-643.
20. Hung JJ, Jeng WJ, Hsu WH, et al. Prognostic factors in pathological stage IB nonsmall cell lung cancer greater than 3 cm. Eur Respir J 2010;36:1355-1361.
21. Travis WD, Colby TB, Corrin B, et al. Histological typing of tumors of lung and pleura. In LH Sobin (Ed.) World Health Organization International Classification of Tumours, 3rd Ed. New York: SpringerVerlag, 1999:21-47.
22. Martini N Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975;70:606-612.
23. Kaplan EL, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457-481.
24. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-622.
25. El-Sherif A, Gooding WE, Santos R, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg 2006;82:408-415.
26. Nakamura H, Kawasaki N, Taguchi M, Kabasawa K. Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis. Br J Cancer 2005;92:1033-1037. (Pubitemid 40546665)
27. Wisnivesky J P, Henschke CI, Swanson S, et al. Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg 2010;251:550-554.
28. Pepek JM, Chino J P, Marks LB, et al. How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems. J Thorac Oncol 2011;6:757-761.
29. Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K. Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification. Chest 2011;139:855-861.
30. Sawyer TE, Bonner JA, Gould PM, Deschamps C, Lange CM, Li H. Patients with stage I non-small cell lung carcinoma at postoperative risk for local recurrence, distant metastasis, and death: implications related to the design of clinical trials. Int J Radiat Oncol Biol Phys 1999;45:315-321. (Pubitemid 29408544)
31. Varlotto JM, Recht A, Nikolov M, Flickinger JC, Decamp MM. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer. Cancer 2009;115:851-858.
32. Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification. Chest 2011;140:1494-1502.
33. Varlotto JM, Recht A, Flickinger JC, Medford-Davis LN, Dyer AM, Decamp MM. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer. Cancer 2009;115:1059-1069.
34. Maeda R, Yoshida J, Ishii G, et al. Long-term outcome and late recurrence in patients with completely resected stage IA non-small cell lung cancer. J Thorac Oncol 2010;5:1246-1250.
35. Maeda R, Yoshida J, Ishii G, et al. Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3 cm in maximum dimension. Chest 2010;138:357-362.
36. Hanagiri T, Sugio K, Mizukami M, et al. Significance of Smoking as a Postoperative Prognostic Factor in Patients with Non-small Cell Lung Cancer. J Thorac Oncol 2008;3:1127-1132.
37. Bryant A Cerfolio RJ. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest 2007;132:185-192. (Pubitemid 47068220)
38. Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K. The prognostic impact of cigarette smoking on patients with non-small cell lung cancer. J Thorac Oncol 2011;6:735-742.
39. Maeda R, Ishii G, Yoshida J, Hishida T, Nishimura M, Nagai K. Influence of cigarette smoking on histological subtypes of stage I lung adenocarcinoma. J Thorac Oncol 2011;6:743-750.